Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms
The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous ope...
Saved in:
Published in | Progress in Nucleic Acid Research and Molecular Biology Vol. 70; pp. 33,IN1,55 - 54,IN2,75 |
---|---|
Main Authors | , , , , , , , , |
Format | Book Chapter Journal Article |
Language | English |
Published |
United States
Elsevier Science & Technology
2001
|
Subjects | |
Online Access | Get full text |
ISBN | 0125400705 9780125400701 |
ISSN | 0079-6603 |
DOI | 10.1016/S0079-6603(01)70013-X |
Cover
Abstract | The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is acomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes. |
---|---|
AbstractList | The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is acomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes. The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the contnuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg super(2+) dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is acomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca super(2+)sensitive tissues by elevating PDP1 activity via the Ca super(2+)dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes. PDC, pyruvate dehydrogenase complex; PDK, pyruvate dehyorogenase kinase; PDP, pyruvate dehydrogenase phosphatase; E1, pyruvata dehydrogenase; E2, dihydrolipoyl acetyitransferase; L1, N-terminal lipoyi domain of E2; L2, inner lipoyl domain of E2; E3, dihydrolipoyl dehydrogenase; E3BP, E3-binding protein (formerly protein X); L3, lipoyl domain of E3BP; GST, glutathione-S-transfenase; OCA, dichloroacetate; PPAR-a, peroxisome proliferator-activated receptor-a. The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the continuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is accomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes. The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the continuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is accomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes.The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of oxidative energy or as precursors in the biosynthesis of fatty acids. The activity of this mitochondrial complex is regulated by the continuous operation of competing pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP) reactions. The resulting interconversion cycle determines the fraction of active (nonphosphorylated) pyruvate dehydrogenase (E1) component. Tissue-specific and metabolic state-specific control is achieved by the selective expression and distinct regulatory properties of at least four PDK isozymes and two PDP isozymes. The PDK isoforms are members of a family of serine kinases that are not structurally related to cytoplasmic Ser/Thr/Tyr kinases. The catalytic subunits of the PDP isoforms are Mg2+-dependent members of the phosphatase 2C family that has binuclear metal-binding sites within the active site. The dihydrolipoyl acetyltransferase (E2) and the dihydrolipoyl dehydrogenase-binding protein (E3BP) are multidomain proteins that form the oligomeric core of the complex. One or more of their three lipoyl domains (two in E2) selectively bind each PDK and PDP1. These adaptive interactions predominantly influence the catalytic efficiencies and effector control of these regulatory enzymes. When fatty acids are the preferred source of acetyl-CoA and NADH, feedback inactivation of PDC is accomplished by the activity of certain kinase isoforms being stimulated upon preferentially binding a lipoyl domain containing a reductively acetylated lipoyl group. PDC activity is increased in Ca2+-sensitive tissues by elevating PDP1 activity via the Ca2+-dependent binding of PDP1 to a lipoyl domain of E2. During starvation, the irrecoverable loss of glucose carbons is restricted by minimizing PDC activity due to high kinase activity that results from the overexpression of specific kinase isoforms. Overexpression of the same PDK isoforms deleteriously hinders glucose consumption in unregulated diabetes. |
Author | Roche, Thomas E. Baker, Jason C. Peng, Tao Dong, Jianchun Yan, Xiaohua Hiromasa, Yasuaki Kasten, Shane A. Turkan, Ali Gong, Xiaoming |
Author_xml | – sequence: 1 givenname: Thomas E. surname: Roche fullname: Roche, Thomas E. – sequence: 2 givenname: Jason C. surname: Baker fullname: Baker, Jason C. – sequence: 3 givenname: Xiaohua surname: Yan fullname: Yan, Xiaohua – sequence: 4 givenname: Yasuaki surname: Hiromasa fullname: Hiromasa, Yasuaki – sequence: 5 givenname: Xiaoming surname: Gong fullname: Gong, Xiaoming – sequence: 6 givenname: Tao surname: Peng fullname: Peng, Tao – sequence: 7 givenname: Jianchun surname: Dong fullname: Dong, Jianchun – sequence: 8 givenname: Ali surname: Turkan fullname: Turkan, Ali – sequence: 9 givenname: Shane A. surname: Kasten fullname: Kasten, Shane A. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/11642366$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk1v1DAQho0o0N3CTwDlhOAQGH_EcU4IteVDqsQBkPZmOfaka5qNg-1U2n-Pd1s4cOlpNNIz73y9a3IyhQkJeUnhHQUq338HaLtaSuBvgL5tASivN4_IGkBBw1jL5OOSUNaIAkJzQlb_Cp6SlWgltJxRfkrWKf0CYG0H8hk5pVQKxqVckc2FT9lPNlcRr5fR5BD31RzDjDF7TFUYqnkfl1uTsXK43bsYrnEyCasbfwxmctW8DWnemnzIfQpDiLv0nDwZzJjwxX08Iz8_Xf44_1Jfffv89fzjVY2C81xbVcYY0IBiahgYUpC246LpmcCe876THYUenOM49IJT66SCoVGmYQ5bafgZeX2nW4b-vWDKeueTxXE0E4Yl6ZaV_RWTD4JCdZIxIR4EGQUhhGIFfHUPLv0OnZ6j35m413-vWwD6nxL2IdxYnHI0o92aOWMsgl1Znmqq9LH7h7saLEe79Rh1sh4ni85HtFm74DUFfXCHPrpDH56tgeqjO_SG_wGE_Kn0 |
ContentType | Book Chapter Journal Article |
Copyright | 2001 |
Copyright_xml | – notice: 2001 |
DBID | FFUUA CGR CUY CVF ECM EIF NPM 7TM 7S9 L.6 7X8 |
DEWEY | 572.8 |
DOI | 10.1016/S0079-6603(01)70013-X |
DatabaseName | ProQuest Ebook Central - Book Chapters - Demo use only Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nucleic Acids Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | Nucleic Acids Abstracts MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISBN | 0080522726 9780080522722 |
EndPage | 54,IN2,75 |
ExternalDocumentID | 11642366 EBC298281_18_44 S007966030170013X |
Genre | Research Support, U.S. Gov't, P.H.S Review Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: DK18320 |
GroupedDBID | --K --Z -~X .55 .GJ 0R~ 123 3O- 53G 5RE 85S 8N7 8NA 8NF AAXUO AAYSV ABGWT ABMAC ABQQC ABSWN ACGFS ACXMD ADOJD AFDAS AFFNX AFOST AFTJW AGAMA AHPSJ ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN CS3 DU5 F5P FDB G8K HZ~ H~9 JDP MVM O9- SBF SDK SES SHL VQA WH7 X7M XOL YNT ZGI ZKB ZXP 089 20A 38. A4I A4J AAAAS AABBV AAORS AAVWF ADVLN AHMUE ALOFI ALTAS AZZ BBABE CZZ FFUUA HGY MYL AALRI ABDPE AKRWK CGR CUY CVF ECM EIF NPM 7TM ADXHL AHDLI 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-e433t-c8366fea0828ff2e106c9345b24eb33b96910b0dd3efb431cd680f58a52de76a3 |
IEDL.DBID | HGY |
ISBN | 0125400705 9780125400701 |
ISSN | 0079-6603 |
IngestDate | Thu Jul 10 22:24:51 EDT 2025 Fri Jul 11 09:52:37 EDT 2025 Fri Jul 11 11:22:15 EDT 2025 Wed Feb 19 01:26:33 EST 2025 Thu May 29 19:45:58 EDT 2025 Fri Feb 23 02:29:58 EST 2024 |
IsPeerReviewed | false |
IsScholarly | false |
Keywords | DCA L1 L2 L3 GST E1 E2 PDC E3 PDK E3BP PPAR-α PDP |
LCCallNum | QP620.P76eb vol. 70 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-e433t-c8366fea0828ff2e106c9345b24eb33b96910b0dd3efb431cd680f58a52de76a3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 |
OCLC | 476073213 |
PMID | 11642366 |
PQID | EBC298281_18_44 |
PQPubID | 23462 |
PageCount | 22 |
ParticipantIDs | proquest_miscellaneous_72213826 proquest_miscellaneous_48962244 proquest_miscellaneous_21044482 pubmed_primary_11642366 proquest_ebookcentralchapters_298281_18_44 elsevier_sciencedirect_doi_10_1016_S0079_6603_01_70013_X |
PublicationCentury | 2000 |
PublicationDate | 2001 2001-00-00 20010101 |
PublicationDateYYYYMMDD | 2001-01-01 |
PublicationDate_xml | – year: 2001 text: 2001 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Progress in Nucleic Acid Research and Molecular Biology |
PublicationTitleAlternate | Prog Nucleic Acid Res Mol Biol |
PublicationYear | 2001 |
Publisher | Elsevier Science & Technology |
Publisher_xml | – name: Elsevier Science & Technology |
SSID | ssj0027906 ssj0000228915 |
Score | 1.5659925 |
SecondaryResourceType | review_article |
Snippet | The mammalian pyruvate dehydrogenase complex (PDC) plays central and strategic roles in the control of the use of glucose-linked substrates as sources of... |
SourceID | proquest pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 33,IN1,55 |
SubjectTerms | Amino Acid Sequence Animals Biochemistry Biophysics Isoenzymes - chemistry Isoenzymes - physiology isozymes Microbiology (non-medical) Molecular Sequence Data Protein Kinases - chemistry Protein Kinases - physiology Protein-Serine-Threonine Kinases Pyruvate Dehydrogenase (Lipoamide)-Phosphatase - chemistry Pyruvate Dehydrogenase (Lipoamide)-Phosphatase - physiology pyruvate kinase Sequence Homology, Amino Acid |
Title | Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms |
URI | https://dx.doi.org/10.1016/S0079-6603(01)70013-X http://ebookcentral.proquest.com/lib/SITE_ID/reader.action?docID=298281&ppg=44 https://www.ncbi.nlm.nih.gov/pubmed/11642366 https://www.proquest.com/docview/21044482 https://www.proquest.com/docview/48962244 https://www.proquest.com/docview/72213826 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7yuIRc0m7TbtOmOpTSBkxWki3bx5A2XbqQQ2iocxKyJbNLqG283sD--8zI3iw5pIeCwdjoYX96zIw08wngs3GlIiKwILUWDZRC2MCgGAhQtqF8R5kWld7b4lpNb8NfWZTtwOUmFobcKoe5v5_T_Ww9vDkf0DxvFguK8Y2JWlISAwwqMtku7OPAVXSMwfTn3dNCCxG8pHxLwBen_sBNyh1Qds-zg2YSEd9EAyXP5plvY376-nyOrxP-zVcZZM9E2EsqqhdVV0dwSOELjOIKELJXsOOq1zC6qNC4_rtmX5h3-fRr6SPIvtMIr4qOtf2R9HW7Zg0tz7fEs8rqkjXrdvWA-iizbr62bY39DeUeu1_4m6ksa-b1spmbjp4Xy5qU4OUbuL368ftyGgxHLQQulLILikQqVTpDhHZlKRwaikUqwygXIVrbMk8VqhX5xFrpyhx1jsKqZFJGiYmEdbEy8hj2qrpy74CJPLaxUolE0yvkQqRYmpEm4nluZCzcGJINZPpZS2ucxPXW6QzR1oS2nnDt0dbZGM42EGu_lzw4sBY9pEstUvx-rnmiw3AMn54S45ChfRBTuXqFqTiR5CXi5RRhkirUbf5RRiwEsTeqMbztm1o3PTsImlRo0iGa7___P0_goHd1o-sD7HXtyn1E3afLT2H_YnbzZ3bq-_gjiTT6rQ |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcgBxKRToUqA-IARIUdePOMkR9cECpadWCifLiR3tCpFE2Wyl_fedcbJd9VAOSJGiRH4knx8zY898BvhgfaWJCCzKnEMDpRQusigGIpRtKN9RpsVV8La41LNr9SOP8x042cTCkFvlOPcPc3qYrcc3xyOax-1iQTG-CVFLSmKAQUUmfwSPFQpHItCffft9t9BCBC8Z3xLwJVk4cJNyR5Q98OygmUTEN_FIybN55tuYn6G-kOPTlH8OVUb5PRH2kIoaRNX5Hjyj8AVGcQUI2XPY8fUL2P9ao3H9d80-suDyGdbS9yE_pRFelz3rhiPpm27NWlqe74hnlTUVa9fd6gb1Ueb8fO26Bvsbyj32ZxFutnasnTfLdm57el4sG1KCly_h-vzs6mQWjUctRF5J2UdlKrWuvCVCu6oSHg3FMpMqLoRCa1sWmUa1opg6J31VoM5ROp1Oqzi1sXA-0Va-gt26qf0BMFEkLtE6lWh6KS5EhqVZaWNeFFYmwk8g3UBm7rW0wUncbJ3OEG1DaJspNwFtk0_gywZiE_aSRwfWcoB0aUSG388NT41SEzi6S4xDhvZBbO2bFabiRJKXiodTqDTTqNv8o4xECGJv1BN4PTS1aQd2EDSp0KRDNN_8_38ewZPZ1a8Lc_H98uchPB3c3uh6C7t9t_LvUA_qi_ehn98Cp8n7_w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Progress+in+Nucleic+Acid+Research+and+Molecular+Biology&rft.atitle=Distinct+Regulatory+Properties+of+Pyruvate+Dehydrogenase+Kinase+and+Phosphatase+Isoforms&rft.date=2001-01-01&rft.pub=Elsevier+Science+%26+Technology&rft.isbn=9780125400701&rft.volume=70&rft_id=info:doi/10.1016%2FS0079-6603%2801%2970013-X&rft.externalDBID=44&rft.externalDocID=EBC298281_18_44 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Febookcentral.proquest.com%2Fcovers%2F298281-l.jpg |